Pre-Clinical Toxicity Study and Safety Assessment of Candidate Live Pertussis Vaccine for Intranasal Administration
Against the backdrop of mass parenteral immunization by present pertussis vaccines the incidence rate of pertussis is recorded in many countries, as well as among adolescents and adults, according to the World Health Organisation data. The number of cases of pertussis complicated to detect is increa...
Main Authors: | L. N. Sinyashina, E. G. Semin, A. Yu. Medkova, R. A. Siundiukova, G. I. Karataev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Numikom LLC
2019-01-01
|
Series: | Эпидемиология и вакцинопрофилактика |
Subjects: | |
Online Access: | https://www.epidemvac.ru/jour/article/view/625 |
Similar Items
-
Acellular Pertussis Vaccine from Antigens of Freshly Isolated and Vaccine Strains of Bordetella pertussis with Different Genotypic Characteristics
by: E. M. Zaitsev, et al.
Published: (2021-09-01) -
A Clinical Study of the Safety and Tolerability of Live Nasal Vaccines for the Prevention of Pertussis
by: A. Yu. Medkova, et al.
Published: (2021-02-01) -
Safety of Combination Vaccines with Whole Cell Pertussis Component
by: O. V. Perelygina, et al.
Published: (2016-12-01) -
Comparative analysis of whole-cell and acellular pertussis vaccines efficacy in preventing pertussis
by: I. A. Alekseeva, et al.
Published: (2018-02-01) -
Development of a Method and a Scheme for the Use of a Live Recombinant Vaccine "GamLPV". Safety and Tolerability of Double Intranasal Vaccination of Healthy Adult Volunteers
by: G. I. Karataev, et al.
Published: (2022-09-01)